NIH-funded research R01 grant

Understanding how brain signaling affects epilepsy in children

Official title: Translational control in focal cortical malformations and epilepsy

Funded at University of Texas Dallas · NIH-11105074 · Data updated 2026-11-12

This study is looking at how a specific brain condition in kids, called focal cortical dysplasia type II, affects their brain development and causes hard-to-treat seizures, with the hope of finding new ways to help them feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Dallas
NIH-funded
Lab location1 site (Richardson, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$390,000
NIH project number1R01NS142029-01
Project IDNIH-11105074 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years diagnosed with focal cortical dysplasia type II and experiencing seizures.

Less likely to help

Patients with epilepsy not related to focal cortical dysplasia or those outside the age range of 0-11 years may not benefit from this research.

What this research studies

This research investigates focal cortical dysplasia type II (FCDII), a condition in children that leads to brain malformations and seizures resistant to treatment. The study focuses on the mTOR signaling pathway and its role in abnormal brain development and seizure activity. By examining how specific proteins regulate the translation of important mRNAs, the research aims to uncover the mechanisms behind these brain abnormalities and their impact on epilepsy. This could lead to new insights into potential treatments for affected children.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for children suffering from epilepsy caused by focal cortical dysplasia.

How similar studies have gone: Previous research has shown promising results in understanding the role of mTOR signaling in epilepsy, but the specific approach of this study is novel.

Where this research is happening

  • University of Texas Dallas
    Richardson, United States
    Active

Researchers

  • Principal investigator: Nguyen, Lena — University of Texas Dallas
  • Study coordinator: Nguyen, Lena

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.